Arrowhead Research Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Arrowhead Research Corp
TickerARWR
CIK #0000879407
CUSIP04280A100
SectorTrade & Services - Services-Commercial Physical & Biological Research
Address201 South Lake Avenue Suite 703, Pasadena, CA 91101
Source [EDGAR]
CIK Filing 2011 - 2025
[0000879407] 10-K
[0000879407] 10-Q
[0000879407] 3
[0000879407] 4
[0000879407] 5
[0000879407] 8-K
[0000879407] D
[0000879407] SC 13D
[0000879407] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Arrowhead Pharmaceuticals Inc [2025-08-11] 0.0
State Street Corp Arrowhead Pharmaceuticals Inc [2025-05-13] 0.0
Sarepta Therapeutics Inc Arrowhead Pharmaceuticals Inc [2025-02-14] 0.0
State Street Corp Arrowhead Pharmaceuticals Inc [2025-02-05] 0.0
Avoro Capital Advisors LLC Arrowhead Pharmaceuticals Inc [2024-11-14] 7.2
BlackRock Inc Arrowhead Pharmaceuticals Inc [2023-01-20] 12.0
Vanguard Group Inc Arrowhead Pharmaceuticals Inc [2019-10-10] 11.37
State Street Corp Arrowhead Pharmaceuticals Inc [2019-02-13] 5.5
First Manhattan Co Arrowhead Pharmaceuticals Inc [2019-02-11] 6.33
BlackRock Inc Arrowhead Pharmaceuticals Inc [2019-02-08] 7.8
RTW Investments LP Arrowhead Pharmaceuticals Inc [2018-05-14] 5.02
OppenheimerFunds Inc Arrowhead Pharmaceuticals Inc [2018-02-06] 8.42
Silence Therapeutics PLC Arrowhead Pharmaceuticals Inc [2017-12-01] 6.4
Silence Therapeutics PLC Arrowhead Pharmaceuticals Inc [2017-01-13] 0.21
Novartis AG Arrowhead Research Corp [2016-02-12] 5.57
Integrated Core Strategies US LLC Arrowhead Research Corp [2015-04-07] 3.6
BlackRock Inc Arrowhead Research Corp [2015-02-02] 6.2
Oppenheimer Funds Inc Arrowhead Research Corp [2015-01-26] 5.49
Bridger Management LLC Arrowhead Research Corp [2015-01-23] 5.5
Integrated Core Strategies US LLC Arrowhead Research Corp [2014-04-08] 3.0
FMR LLC Arrowhead Research Corp [2014-03-10] 0.0
Baker Bros Advisors LP Arrowhead Research Corp [2014-02-14] 9.99
OrbiMed Advisors LLC Arrowhead Research Corp [2014-02-13] 1.6
Marxe Austin W & Greenhouse David M Arrowhead Research Corp [2014-02-12] 9.99
QVT Financial LP Arrowhead Research Corp [2013-10-18] 5.64
Ridgeback Capital Investments LP Arrowhead Research Corp [2013-10-16] 5.0
SAC Capital Advisors LP Arrowhead Research Corp [2013-10-15] 3.9
Sabby Management LLC Arrowhead Research Corp [2013-05-13] 6.99
RA Capital Management LLC Arrowhead Research Corp [2013-05-09] 0.9
Camber Capital Management LLC Arrowhead Research Corp [2013-05-09] 9.9
Sabby Management LLC Arrowhead Research Corp [2012-08-16] 6.67
Form 3/4/5 Filer 2011 - 2025
Hamilton James C
Arrowhead Pharmaceuticals Inc
Apel Daniel Joseph
Anzalone Christopher Richard
Ingram Douglas S
Olukotun Adeoye Y
Myszkowski Kenneth Allen
O'Brien Patrick
Lu Hongbo
Vakiener Victoria
Waddill William D.
Ferrari Mauro
Perry Michael S
Given Douglas B
Oliver Tracie
San Martin Javier
De Backer Marianne
Hassard James
Bradshaw Curt
Given Bruce D
Li Zhen
Leone Peter Brian
Frykman Edward W
Lewis David L.
McKenney Charles
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 19,120,040 19,424,472
Vanguard Group Inc [2025-06-30] SOLE 0 15,243,118
Avoro Capital Advisors LLC [2025-06-30] SOLE 10,600,000 10,600,000
State Street Corp [2025-06-30] DFND 6,004,663 6,371,056
Slate Path Capital LP [2025-06-30] SOLE 5,232,000 5,232,000
FMR LLC [2025-06-30] DFND 5,141,099 5,170,310
Geode Capital Management LLC [2025-06-30] DFND 2,978,505 2,978,505
Siren, L.L.C. [2025-06-30] DFND 2,669,880 2,669,880
Goldman Sachs Group Inc [2025-06-30] DFND 2,188,181 2,196,614
Marshall Wace LLP [2025-06-30] OTR 0 2,155,998
Norges Bank [2025-06-30] SOLE 1,924,957 1,924,957
Morgan Stanley [2025-06-30] DFND 1,620,485 1,705,266
UBS Group AG [2025-06-30] DFND 1,185,766 1,600,596
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 1,205,761 1,304,797
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] OTR 12,414 1,249,156
Northern Trust Corp [2025-06-30] DFND 1,202,333 1,206,221
Charles Schwab Investment Management Inc [2025-06-30] SOLE 1,170,644 1,170,745
Aberdeen Group plc [2025-06-30] DFND 960,245 960,245
Baker Bros Advisors LP [2025-06-30] SOLE 939,174 939,174
Western Financial Corp/CA [2025-06-30] SOLE 820,239 820,239
Bank of New York Mellon Corp [2025-06-30] DFND 774,573 818,079
Invesco Ltd. [2025-06-30] DFND 0 762,665
Woodline Partners LP [2025-06-30] SOLE 746,156 746,156
Bank of America Corp /DE/ [2025-06-30] DFND 121,488 625,996
Principal Financial Group Inc [2025-06-30] DFND 623,097 623,097
Privium Fund Management B.V. [2025-06-30] SOLE 612,214 612,214
Trexquant Investment LP [2025-06-30] SOLE 503,654 503,654
Schonfeld Strategic Advisors LLC [2025-06-30] SOLE 482,055 482,055
Fisher Asset Management LLC [2025-06-30] DFND 327,528 451,655
Public Sector Pension Investment Board [2025-06-30] SOLE 428,386 428,386
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com